Medical Condition News

RSS

Frontline healthcare workers experienced highest insomnia rates during and after pandemic

An analysis co-led by Josefa A. Antón Ruiz, a researcher from the Department of Health Psychology at the University of Alicante (UA), reveals that 43.5% of healthcare professionals experienced clinically significant symptoms of insomnia during and after the COVID-19 pandemic.

23 Feb 2026

Study finds widespread off-label use of antipsychotics among older people

The use of antipsychotic medications for purposes other than those officially approved is common among older adults in Finland.

23 Feb 2026

Researchers show red blood cells drive better glucose tolerance at high altitude

Chronic hypoxia improves glucose tolerance in mice through insulin-independent mechanisms, with red blood cells acting as a major systemic glucose sink. Increased erythrocyte production and altered glycolytic flux help reduce circulating glucose while supporting oxygen delivery to tissues.

22 Feb 2026

New review explores whether berries can slow cognitive decline linked to obesity

This systematic review in Nutrients evaluates human studies investigating whether polyphenol-rich berry consumption can modulate obesity-related metabolic dysfunction and support cognitive performance, particularly in individuals at risk of mild cognitive impairment. Evidence suggests modest memory benefits and possible metabolic improvements, although biomarker findings and long-term clinical relevance remain uncertain.

22 Feb 2026

Study identifies PPP2R5C blood marker that may detect Alzheimer’s disease earlier

Emerging evidence suggests reduced plasma PPP2R5C levels may serve as an early indicator of Alzheimer’s disease before overt clinical symptoms appear. The protein appears linked to tau regulation, autophagy pathways, and cognitive decline, supporting its potential diagnostic relevance.

22 Feb 2026

Blood test models predict when Alzheimer’s symptoms may start years in advance

Researchers developed plasma p-tau217–based clock models that estimate when cognitively unimpaired individuals with Alzheimer’s pathology may develop symptomatic disease. The models predicted symptom onset within about three to four years and may help improve clinical trial selection while remaining unsuitable for individual clinical decisions at present.

22 Feb 2026

Certain brain regions found to be more active in people with obsessive-compulsive disorder

A new study revealed that certain brain regions are more active in people with obsessive-compulsive disorder (OCD) during cognitively demanding tasks.

22 Feb 2026

Hormone-driven immune cells may explain sex differences in chronic pain

Chronic pain lasts longer for women than men, and new research suggests differences in hormone-regulated immune cells, called monocytes, may help explain why.

22 Feb 2026

Indoor air quality plays major role in adult asthma symptoms

For adults with asthma, having fans, air purifiers or other ventilation and exhaust systems - especially in kitchens and bathrooms - is one of the best ways to reduce the risk of flare-ups at home.

20 Feb 2026

Single prenatal exposure to fungicide linked to disease across 20 generations

A single exposure to a toxic fungicide during pregnancy can increase the risk of disease for 20 subsequent generations - with inherited health problems worsening many generations after exposure.

20 Feb 2026

Smarter timing of cancer treatments could improve cure rates, study suggests

A new study provides hope that smarter timing of cancer treatments could improve cure rates.

20 Feb 2026

Milken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for sarcoidosis

The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future clinical trial in cutaneous sarcoidosis.

20 Feb 2026

Discovery offers hope for reducing immune-related heart risks in cancer patients

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives.

20 Feb 2026

Adults with intellectual and developmental disabilities face severe mental health disparities

Adults with intellectual and developmental disabilities, such as autism and Down syndrome, experience substantially higher rates of anxiety and depression than the general population of adults, researchers reported today in JAMA Network Open.

20 Feb 2026

Cannabis use in adolescence associated with higher rates of psychiatric disorders

Adolescents who use cannabis could face a significantly higher risk of developing serious psychiatric disorders by young adulthood, according to a large new study published today in JAMA Health Forum.

20 Feb 2026

Optimized costimulatory domains boost tumor killing in CAR NK cells

Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new models of chimeric antigen receptors (CARs) with specific costimulatory domains, such as 2B4 and DAP12.

20 Feb 2026

Grant supports research into how microglia may spread toxic tau in Alzheimer’s

A researcher with the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio has received a two-year, $402,500 grant award from the Cure Alzheimer's Fund to study how microglia, the brain's resident immune cells, paradoxically might contribute to the spread of toxic forms of tau protein in the disease.

20 Feb 2026

Distinct gut toxicity patterns emerge with targeted cancer treatments

A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled "Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection."

20 Feb 2026

Physical function metrics improve mortality prediction in elderly heart failure patients

Current models of mortality risk after heart failure (HF) rely primarily on cardiac-specific clinical variables and may underestimate risk in elderly East Asian patients.

20 Feb 2026

Rising primary PCI rates do not correlate with lower heart attack mortality in Europe

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented today at the EAPCI Summit 2026.

20 Feb 2026

Medical Condition News

Frontline healthcare workers experienced highest insomnia rates during and after pandemic

Study finds widespread off-label use of antipsychotics among older people

Researchers show red blood cells drive better glucose tolerance at high altitude

New review explores whether berries can slow cognitive decline linked to obesity

Study identifies PPP2R5C blood marker that may detect Alzheimer’s disease earlier

Blood test models predict when Alzheimer’s symptoms may start years in advance

Certain brain regions found to be more active in people with obsessive-compulsive disorder

Hormone-driven immune cells may explain sex differences in chronic pain

Indoor air quality plays major role in adult asthma symptoms

Single prenatal exposure to fungicide linked to disease across 20 generations

Smarter timing of cancer treatments could improve cure rates, study suggests

Milken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for sarcoidosis

Discovery offers hope for reducing immune-related heart risks in cancer patients

Adults with intellectual and developmental disabilities face severe mental health disparities

Cannabis use in adolescence associated with higher rates of psychiatric disorders

Optimized costimulatory domains boost tumor killing in CAR NK cells

Grant supports research into how microglia may spread toxic tau in Alzheimer’s

Distinct gut toxicity patterns emerge with targeted cancer treatments

Physical function metrics improve mortality prediction in elderly heart failure patients

Rising primary PCI rates do not correlate with lower heart attack mortality in Europe

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News